Syndrome News and Research

RSS

Microbiome discovery may help improve treatment for patients with gastrointestinal diseases

University of Calgary researchers probing the gut - "the inner tube of life" - have for the first time discovered specific factors in its workings that in the future may help improve treatment for patients facing gut damage or gastrointestinal disease.

12 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

COVID-19 vaccination humoral immune response in individuals with diabetes

A new study investigated the humoral immune response and side effects related to COVID-19 vaccines in individuals with type 1 diabetes and type 2 diabetes.

12 Nov 2021

Study suggests rattlesnake venom peptide inhibits SARS-CoV-2 replication and transcription

New research suggests a small cationic peptide known as crotamine may inhibit the replication and transcription of SARS-CoV-2.

12 Nov 2021

Potential remaining COVID-19 burden in European countries

The researchers suggest governments should implement public health policies and non-pharmaceutical efforts to encourage vaccine-induced immunity.

12 Nov 2021

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.

12 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

The Protective Immunity from T-cells to COVID-19 in Healthcare workers (PITCH) is a prospective, cohort, multi-center study enclosed within the SIREN study designed to assess the effectiveness of the BNT162b2 vaccine in healthcare workers.

12 Nov 2021

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Researchers explained their analysis of the mechanisms that trigger the docking of SARS-CoV-2 variants to ACE2 and the antibodies, referred to as protein-protein docking.

12 Nov 2021

Research finds greater mortality risk among rural COVID patients in ICUs than urban counterparts

The earliest wave of COVID-19 spared much of rural America, striking people who live in urban areas with far more frequency. The latest surge was different, however. Nonmetropolitan COVID cases outpaced metropolitan ones. So did overall COVID mortality rates.

11 Nov 2021

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.

11 Nov 2021

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

A recent study looks at how mRNA vaccination affects hospitalization and ICU admission in COVID-19 breakthrough infections.

11 Nov 2021

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.

11 Nov 2021

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

Researchers discuss a highly sensitive, specific, and rapid SARS-CoV-2 detection platform by coupling the RT-LAMP with glass nanopore sensors.

11 Nov 2021

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

A group of scientists from Israel sought to evaluate the long-term effectiveness of the BioNTech/Pfizer mRNA BNT162b2 vaccine.

11 Nov 2021

Urothelial cancers in Lynch Syndrome patients can be detected using a simple, cheap urine test

Researchers have shown for the first time that it is possible to detect signs of urothelial cancer using a simple, postal, urine test in Lynch Syndrome (LS) patients who are at high risk of developing tumors.

11 Nov 2021

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

A clinical trial has found that the combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukemia, or APL.

11 Nov 2021

Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

Researchers have been investigating which other proteins remain prevalent long enough for tests against them to be worthwhile.

11 Nov 2021

New Delta sublineage shows no additional resistance to neutralization

Researchers are attempting to determine the ability of this new sublineage to avoid neutralization by antibodies elicited from vaccination.

11 Nov 2021

Syndrome News and Research

Microbiome discovery may help improve treatment for patients with gastrointestinal diseases

Potential therapeutic targets of hydrogen for treatment of the COVID-19

COVID-19 vaccination humoral immune response in individuals with diabetes

Study suggests rattlesnake venom peptide inhibits SARS-CoV-2 replication and transcription

Potential remaining COVID-19 burden in European countries

Will the future of global health rely upon addressing air pollution?

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Research finds greater mortality risk among rural COVID patients in ICUs than urban counterparts

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

Urothelial cancers in Lynch Syndrome patients can be detected using a simple, cheap urine test

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

New Delta sublineage shows no additional resistance to neutralization

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News